Follow
Golbarg Esfahani
Golbarg Esfahani
PhD, Department of pharmaceutical Technology, Martin Luther University Halle-Wittenberg
Verified email at pharmazie.uni-halle.de - Homepage
Title
Cited by
Cited by
Year
Ocular delivery system for propranolol hydrochloride based on nanostructured lipid carrier
B Sharif Makhmal Zadeh, H Niro, F Rahim, G Esfahani
Scientia pharmaceutica 86 (2), 16, 2018
392018
Permeability of ciprofloxacin-loaded polymeric micelles including ginsenoside as P-glycoprotein inhibitor through a Caco-2 cells monolayer as an intestinal absorption model
B Sharif Makhmal Zadeh, G Esfahani, A Salimi
Molecules 23 (8), 1904, 2018
212018
Polymeric micelle as a new carrier in Oral drug delivery systems
A Salimi, BS Makhmalzadeh, G Esfahani
Asian J. Pharm 11 (4), 704-711, 2017
92017
Controlled release starch-lipid implant for the therapy of severe malaria
G Esfahani, O Häusler, K Mäder
International Journal of Pharmaceutics 622, 121879, 2022
82022
Formulation, characterization and in vitro/ex vivo evaluation of trolamine salicylate-loaded transfersomes as transdermal drug delivery carriers
BS Makhmalzadeh, A Salimi, A Nazarian, G Esfahani
International Journal of Pharmaceutical Sciences and Research 9 (9), 3725-3731, 2018
82018
Polymeric Micelle as a New Carrier in Oral Drug Delivery Systems
G Esfahani
Asian Journal of Pharmaceutics (AJP) 11 (04), 2017
32017
A starch-based implant as a controlled drug release system: Non-invasive in vivo characterization using multispectral fluorescence imaging.
G Esfahani, H Lucas, F Syrowatka, K Mäder
Journal of Controlled Release 358, 358-367, 2023
22023
Characterization of Starch-based System for Parenteral Controlled Drug Release Applications
G Esfahani
Martin-Luther-Universität Halle-Wittenberg, 2024
2024
Characterization of Controlled Release Starch-Nimodipine Implant for Antispasmodic and Neuroprotective Therapies in the Brain
G Esfahani, ML Trutschel, D Reichert, K Mäder
Molecular Pharmaceutics 20 (11), 5753-5762, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–9